TAYLOR BEN R (Chief Financial Officer) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/17/2026ACC: 0001712276-26-000007
Officer· Chief Financial Officer
Since Feb 2026
-5.40K
Net shares
Net seller
$17.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
5.40K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−5.40K
Price / share
$3.15
Trade value
$17K
% of position
0.5%
6/15/2026
1.11M→1.10M
Total
Net shares
−5.40K
Net value
-$17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/15/2026 | F · Tax Withholding | −5.40K | $3.15 | $17K | 0.5% | 1.11M | 1.10M |
| Total | −5.40K | -$17K | ||||||
Derivative Transactions0
No derivative transactions reported